Investing in Impact: Announcing Our First 2026 Research Grants
We are pleased to begin announcing the projects that will be funded through our 2026 research investment of £100,000. This funding has been carefully designed to support both shorter-term, practice-based improvements and longer-term innovation to enhance outcomes for...
New report launched on World Cancer Day highlights the hidden impact of neuroendocrine cancer
On World Cancer Day 2026, we are proud to launch our new report, The invisible cancer: How delays, misdiagnosis and unequal treatment of neuroendocrine cancer in the UK are costing lives, shining a spotlight on a cancer that remains widely misunderstood and too often...
The James Lind Alliance Neuroendocrine Cancer Priority Partnership Steering Group
Hi – my name is Elaine and I’m a member of the Manchester Patient Support Group. I was diagnosed with an insulinoma almost 14 years ago and am under the care of The Christie NET Centre of Excellence. During one of our meetings in the summer, I was asked if I would...